Showing results (271-280 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|October 29, 2021
Oncogene-mediated metabolic gene signature predicts breast cancer outcomeMerve Aslan, En-Chi Hsu, Fernando J Garcia-Marques, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
NPJ Breast Cancer|October 13, 2021
Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expressionChristina Horr, Steven A Buechler
NPJ Breast Cancer|October 13, 2021
Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|July 11, 2022
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerRachel Yoder, Bruce F Kimler, Joshua M Staley, et al.
NPJ Breast Cancer|July 19, 2022
TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospectsKojo Agyemang, Allan M Johansen, Grayson W Barker, et al.
NPJ Breast Cancer|April 28, 2022
Is conservative management of ductal carcinoma in situ risky?Lan Zheng, Yesim Gökmen-Polar, Sunil S Badve
NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.
NPJ Breast Cancer|June 27, 2019
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxelSorbarikor Piawah, Colby Hyland, Sarah E Umetsu, et al.
NPJ Breast Cancer|February 9, 2022
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancerJoseph A Sparano, Anne O'Neill, Noah Graham, et al.
Pageof 98